Providing patients and health care professionals access to the on-going clinical trials thatare open for patient enrollment
GVHD (RWH 313-99): A Phase I Trial of Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis after Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)
DLBCL (RWH 390-99): Ofatumumab versus Rituximab Salvage Chemoimmunotherapy Followed by ASCT in Relapsed or Refractory DLBCL